These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9620996)

  • 21. Expression of the gag-pol fusion protein of Moloney murine leukemia virus without gag protein does not induce virion formation or proteolytic processing.
    Felsenstein KM; Goff SP
    J Virol; 1988 Jun; 62(6):2179-82. PubMed ID: 2452901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The virion-associated Gag-Pol is decreased in chimeric Moloney murine leukemia viruses in which the readthrough region is replaced by the frameshift region of the human immunodeficiency virus type 1.
    Gendron K; Dulude D; Lemay G; Ferbeyre G; Brakier-Gingras L
    Virology; 2005 Apr; 334(2):342-52. PubMed ID: 15780884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Host cell cathepsins potentiate Moloney murine leukemia virus infection.
    Kumar P; Nachagari D; Fields C; Franks J; Albritton LM
    J Virol; 2007 Oct; 81(19):10506-14. PubMed ID: 17634228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of infectious murine leukemia virus production by Fv-4 env gene products exerting dominant negative effect on viral envelope glycoprotein.
    Takeda A; Matano T
    Microbes Infect; 2007; 9(14-15):1590-6. PubMed ID: 18023391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ribozyme-mediated suppression of Moloney murine leukemia virus and human immunodeficiency virus type I replication in permissive cell lines.
    Sun LQ; Warrilow D; Wang L; Witherington C; Macpherson J; Symonds G
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9715-9. PubMed ID: 7937878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of producer cell-dependent restriction of murine leukemia virus replication.
    Serhan F; Jourdan N; Saleun S; Moullier P; Duisit G
    J Virol; 2002 Jul; 76(13):6609-17. PubMed ID: 12050374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of cleavage of Moloney murine leukemia virus gag and env coded precursor polyproteins by cerulenin.
    Ikuta K; Luftig RB
    Virology; 1986 Oct; 154(1):195-206. PubMed ID: 3489314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cooperative effect of gag proteins p12 and capsid during early events of murine leukemia virus replication.
    Lee SK; Nagashima K; Hu WS
    J Virol; 2005 Apr; 79(7):4159-69. PubMed ID: 15767417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations altering the moloney murine leukemia virus p12 Gag protein affect virion production and early events of the virus life cycle.
    Yuan B; Li X; Goff SP
    EMBO J; 1999 Sep; 18(17):4700-10. PubMed ID: 10469649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of recombinant nonecotropic murine leukemia viruses from the wild mouse species Mus spretus.
    Jung YT; Wu T; Kozak CA
    J Virol; 2003 Dec; 77(23):12773-81. PubMed ID: 14610199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fv-1 N- and B-tropism-specific sequences in murine leukemia virus and related endogenous proviral genomes.
    Boone LR; Glover PL; Innes CL; Niver LA; Bondurant MC; Yang WK
    J Virol; 1988 Aug; 62(8):2644-50. PubMed ID: 2839691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intact Viral Particle Counts Measured by Flow Virometry Provide Insight into the Infectivity and Genome Packaging Efficiency of Moloney Murine Leukemia Virus.
    Renner TM; Tang VA; Burger D; Langlois MA
    J Virol; 2020 Jan; 94(2):. PubMed ID: 31694951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of an envelope mutant of HIV-1 that interferes with viral infectivity.
    Chen SS; Ferrante AA; Terwilliger EF
    Virology; 1996 Dec; 226(2):260-8. PubMed ID: 8955046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of interaction between Trim28 and YY1 in silencing proviral DNA of Moloney murine leukemia virus.
    Lee A; CingÖz O; Sabo Y; Goff SP
    Virology; 2018 Mar; 516():165-175. PubMed ID: 29407374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid reversion of a deletion mutation in Moloney murine leukemia virus by recombination with a closely related endogenous provirus.
    Martinelli SC; Goff SP
    Virology; 1990 Jan; 174(1):135-44. PubMed ID: 2294637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal by dithiothreitol treatment of the block in murine leukemia virus maturation induced by disulfide cross-linking.
    Campbell S; Oshima M; Mirro J; Nagashima K; Rein A
    J Virol; 2002 Oct; 76(19):10050-5. PubMed ID: 12208984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preliminary studies on the design of retroviral vectors for substitutive gene therapy].
    Martín F; Jean-Mairet Y; Talavera A
    Microbiologia; 1996 Mar; 12(1):43-50. PubMed ID: 9019133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular cloning, complete sequence, and biological characterization of a xenotropic murine leukemia virus constitutively released from the human B-lymphoblastoid cell line DG-75.
    Raisch KP; Pizzato M; Sun HY; Takeuchi Y; Cashdollar LW; Grossberg SE
    Virology; 2003 Mar; 308(1):83-91. PubMed ID: 12706092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of infectious recombinant Moloney murine leukemia virus particles in BHK cells using Semliki Forest virus-derived RNA expression vectors.
    Li KJ; Garoff H
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11658-63. PubMed ID: 8876192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "sarc" sequence transcription in Moloney sarcoma virus-transformed nonproducer cell lines.
    Bondurant M; Ramabhadran R; Green M; Wold WS
    J Virol; 1979 Jan; 29(1):76-82. PubMed ID: 430602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.